The Global Pediatric Perfusion Market Will Grow At Highest Pace Owing To Rising Number Of Complex Congenital Heart Disease Surgeries

 

 Global Pediatric Perfusion Market 

Pediatric perfusion refers to the use of cardiopulmonary bypass during open-heart surgery in children and infants. It involves diverting a child's blood through an oxygenator and returning it to circulate through the body during surgery to correct heart defects or conditions present from birth. The demand for pediatric cardiopulmonary bypass equipment and heart-lung machines has increased significantly due to rising number of complex congenital heart diseases among newborns and infants. Pediatric perfusion equipment is specifically designed for children and carefully manages blood flow and pressure for very small patients.

The Global Pediatric Perfusion Market is estimated to be valued at US$ 574.7 MN in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Global Pediatric Perfusion Market Size are Medtronic, GE Healthcare, LivaNova, Inc., Getinge, Braile Biomedica, XENIOS AG, BL Lifesciences, Terumo Corporation, 3M, Koninklijke Philips N.V., EUROSETS, Merck KGaA, Stryker, Cardinal Health, Nonin, and Sorin Group USA, Inc. These players are focusing on developing advanced systems to meeting the needs of growing pediatric cardiac surgeries.

The number of cardiac surgeries in children, including surgeries for conditions like tetralogy of Fallot, ventricular septal defects, and atrioventricular septal defects has increased greatly. As per some estimates, over 25,000 pediatric cardiac surgeries are performed in the U.S. annually. The rising disease incidence is expected to propel the demand for pediatric perfusion equipment and services.

Technological advancements like miniaturized cardiopulmonary bypass machines, dexterous cannulas, and membrane oxygenators have made cardiac procedures safer for neonates and infants. Advance perfusion monitoring equipment also helps perfusionists in maintaining optimal parameters during complex procedures. These developments are supporting the increase in referrals for advanced cardiac care in children.

Market Trends

The pediatric perfusion market is witnessing growing preference for less invasive surgeries using newer technologies. Minimally invasive cardiac surgeries are gaining ground as they are associated with less pain, fewer complications, shorter hospital stay, and quicker recovery times in children. Market players are developing compact extracorporeal life support systems that can provide cardiac and respiratory support to infants weighing less than 3 kg.

Heightened awareness programs about congenital heart diseases and their treatment options have encouraged more parents to seek professional help for children with heart conditions. This is helping in early diagnosis and treatment. Additionally, improving reimbursement structures in major countries are making quality cardiac care affordable for more families.

Market Opportunities

The development of next-generation miniaturized heart-lung machines optimized for low-weight neonates offers an opportunity for market expansion. Additionally, newer designs of rotary blood pumps and ventricular assist devices with pediatric applications hold promise.

Adoption of simulation-based training systems for pediatric extracorporeal life support and regular skill upgrading of pediatric cardiologists, surgeons, and perfusionists present avenues for sustained growth of the market.

Impact of COVID-19 on Global Pediatric Perfusion Market growth:

The COVID-19 pandemic has significantly impacted the growth of the global pediatric perfusion market. During the initial periods of the pandemic, major healthcare resources were diverted towards treating COVID-19 patients which led to postponement of non-emergency surgeries and cardiac procedures involving children. This negatively impacted the demand for pediatric perfusion products and services. However, with resumption of elective surgeries post relaxation of lockdown measures, the market has witnessed a steady recovery. Nevertheless, supply chain disruptions caused due to restrictions and raw material shortages continue to pose challenges for market players. Going forward, demand is expected to rise steadily with growing focus on timely treatment of pediatric cardiac conditions. Manufacturers will need to ensure stable supply chains and optimize production to cater to the increasing need. They also need to explore opportunities in developing innovative pediatric perfusion solutions that can help expand access and efficiently manage pediatric cardiopulmonary bypass procedures during such pandemic situations.

Geographical concentration of Global Pediatric Perfusion Market:

In terms of value, North America holds the major share of the global pediatric perfusion market owing to presence of advanced healthcare facilities, growing pediatric cardiac disease burden, and favorable reimbursement scenario in countries like the United States. Within the region, the U.S. accounts for the largest market. Meanwhile, Europe is emerging as the second largest regional market supported by increasing focus on pediatric healthcare across countries.

Fastest growing region for Global Pediatric Perfusion Market:

Asia Pacific region is poised to witness the fastest growth in the global pediatric perfusion market over the forecast period owing to rapidly developing healthcare infrastructure, increasing medical tourism, growing pediatric population and rising economic ability of people to spend on advanced pediatric healthcare services. Moreover, presence of emerging economies like India and China offering immense opportunities for market players to capitalize on will further drive the market growth in the region.

 

Get more insights on This Topic- Global Pediatric Perfusion Market